Invalid date chosen. Displaying data for the latest date instead.

Technical Analysis for BJDX - Bluejay Diagnostics, Inc.

Grade Last Price % Change Price Change
F 0.58 0.87% 0.01
BJDX closed up 0.87 percent on Friday, May 17, 2024, on 29 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
20 DMA Support Bullish 0.00%
Gapped Down Weakness 0.00%
Crossed Above 20 DMA Bullish 0.87%
Outside Day Range Expansion 0.87%
Gapped Up Strength 0.87%
Fell Below 20 DMA Bearish 10.48%
180 Bearish Setup Bearish Swing Setup 10.48%
Boomer Sell Setup Bearish Swing Setup 10.48%

   Recent Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bluejay Diagnostics, Inc. Description

Bluejay Diagnostics, Inc., an in-vitro diagnostic company, develops, manufactures, and markets minimally invasive point-of-care (POC) diagnostics tests and devices for infectious disease, inflammation, and oncology markets in the United States. It is developing Symphony biomarker detection platform for the detection of sepsis, cancer, cardiac ishcemia, and congestive heart failure. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. It has a collaboration agreement with Toray Industries, Inc. to develop a point of care test for covid-19 patient triage; and a research and development agreement with Naval Medical Research Center to develop lateral flow rapid test for diagnosis of various tick-borne diseases, including Lyme disease. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Biotechnology Cancer Clinical Medicine Infectious Diseases Inflammation Biomarkers Allergy Allergic Conjunctivitis Chemical Pathology Congestive Heart Failure Sepsis Conjunctivitis Lyme Disease Tick Borne Diseases

Is BJDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.9799
52 Week Low 0.39
Average Volume 50,297
200-Day Moving Average 2.65
50-Day Moving Average 0.66
20-Day Moving Average 0.55
10-Day Moving Average 0.54
Average True Range 0.07
RSI (14) 50.25
ADX 37.83
+DI 14.03
-DI 19.23
Chandelier Exit (Long, 3 ATRs) 0.46
Chandelier Exit (Short, 3 ATRs) 0.60
Upper Bollinger Bands 0.63
Lower Bollinger Band 0.47
Percent B (%b) 0.69
BandWidth 28.96
MACD Line -0.03
MACD Signal Line -0.04
MACD Histogram 0.0133
Fundamentals Value
Market Cap 1.03 Million
Num Shares 1.78 Million
EPS -9.64
Price-to-Earnings (P/E) Ratio -0.06
Price-to-Sales 34.80
Price-to-Book 0.26
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.68
Resistance 3 (R3) 0.67 0.64 0.66
Resistance 2 (R2) 0.64 0.61 0.64 0.65
Resistance 1 (R1) 0.61 0.60 0.62 0.61 0.65
Pivot Point 0.57 0.57 0.58 0.57 0.57
Support 1 (S1) 0.54 0.55 0.56 0.55 0.51
Support 2 (S2) 0.51 0.53 0.51 0.51
Support 3 (S3) 0.48 0.51 0.50
Support 4 (S4) 0.48